ReviewGlobal cardiology science & practice2022
Middle aortic syndrome in children and adolescents.
Review in Global cardiology science & practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 10 citations in OpenAlex.
- Reoperative repair of recurrent anastomotic pseudoaneurysm following aorto-aortic bypass for middle aortic syndrome.Journal of vascular surgery cases and innovative techniques · 2026Article
- Mid-aortic syndrome in two Saudi children with refractory hypertension: a case report.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026Article
- The Hidden Constriction: Middle Aortic Syndrome Presenting as Acute Systolic Heart Failure in a 7-Month-Old Infant.CASE (Philadelphia, Pa.) · 2026Article
- Feasibility and Early and Midterm Outcomes of Midaortic Syndrome: A Retrospective Cohort Study.Journal of clinical medicine · 2025Article
- Long Segment Coarctation of the Abdominal Aorta in a 12-Year-Old Patient: A Case Report.Cureus · 2025Article
- Pediatric Renovascular Hypertension: Diagnosis and Management.Seminars in interventional radiology · 2025Review
- Complex aortic reconstruction for a type IV midaortic syndrome.JTCVS techniques · 2025Article
- Parallel endograft repair of an aortic anastomotic pseudoaneurysm in a patient with middle aortic syndrome.Journal of vascular surgery cases and innovative techniques · 2025Article
- Middle aortic syndrome in childhood-onset Takayasu arteritis.Journal of vascular surgery cases and innovative techniques · 2025Article
- Renal Artery Stenosis and Mid-Aortic Syndrome in Children-A Review.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Middle aortic syndrome is a rare form of renovascular disease that may present with severe hypertension during childhood. Narrowing of the abdominal aorta is often associated with narrowing of the renal and/or other visceral arteries and may be secondary to specific genetic syndromes. Following the optimization of blood pressure control, significant aortic narrowing often requires invasive management, including endovascular and surgical intervention. In younger children, endovascular therapy may be attempted in the first instance to acutely reduce the pressure gradient across the narrowing; however, a sustained benefit is rare. Once the child has grown to accommodate a graft of an adequate size, surgical therapy is indicated for patients in whom medical and/or endovascular management has not resulted in adequate blood pressure control. It is critical that individuals with middle aortic syndrome be managed by an experienced multidisciplinary team that includes medical, endovascular, and surgical expertise that can provide long-term care to monitor for recurrent hypertension and evidence of end-organ damage.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.